Significant increase in the efficiency and speed of atmospheric pressure chemical ionization (APCI) in tandem mass spectrometry (MS/MS) will have a profound impact on its applications to the entire analytical field of characterization of drugs, metabolites, lipids, steroids, etc. A broad applicability of APCI-based MS analysis makes it a unique analytical tool specifically targeting trace amounts of many chemical and biological substances. We plan to build a novel APCI ion source based on atmospheric dielectric barrier discharge (DBD) to significantly improve efficiency and specificity of ACPI-MS based detection method.

Public Health Relevance

Atmospheric pressure ionization is a broadly used technique in the analysis of complex chemical and biological samples providing reliable identification of drugs, disease-specific metabolites, steroids, antibiotics, etc. utilizing mass-spectrometers. We plan to develop a novel APCI source that will provide better sensitivity and specificity. This source will substantially improve and accelerate mass-spectrometry based characterization of biologically important molecules. The source will be easily incorporated into a design of a variety of tandem mass spectrometers.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43GM110881-01
Application #
8715083
Study Section
Special Emphasis Panel (ZRG1-IMST-G (10))
Program Officer
Sheeley, Douglas
Project Start
2014-08-01
Project End
2015-07-31
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
1
Fiscal Year
2014
Total Cost
$164,916
Indirect Cost
Name
Masstech, Inc.
Department
Type
DUNS #
123310083
City
Columbia
State
MD
Country
United States
Zip Code
21046